Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rituximab (rituxan) (1 trial)
inactivated influenza vaccine (1 trial)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Trials (2 total)
Trial APIs (2 total)